News

Boston Scientific, Emblem, S-ICD, UNTOUCHED study, TV-ICDs, MADIT-RIT study

Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is...

SentreHeart, Lariat Suture Delivery Device, FDA, AMAZE Trial, AFib, LAA

SentreHeart Inc. announced that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in a clinical study of...

CardiAQ Valve Technologies, TMVI, second generation, implantation, Tor Vergata

CardiAQ Valve Technologies (CardiAQ) announced that its second-generation transcatheter bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment. The device...

REDUCE FMR, Cardiac Dimensions, Carillon Mitral Contour System, FMR

Cardiac Dimensions announced the first patients have been enrolled in the REDUCE FMR clinical trial. REDUCE FMR is a prospective, double-blind, randomized multi-center trial, evaluating the...

Sunshine Heart, C-Pulse, $2 million, loan, COUNTER HF, heart failure

Sunshine Heart Inc. has borrowed an additional $2 million to continue work on its U.S. pivotal study for the C-Pulse Heart Assist System. The minimally invasive surgically implanted device is...

MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue

New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients annually, according to a new paper. The...

A nationwide study published in the Journal of the American College of Cardiology identified current frequent barriers to cardio-oncology services in the United States. According to the...

fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord

To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient’s body to reject the new...

InspireMD, CGuard, PARADIGM study, EuroPCR 2015, Musialek

InspireMD Inc. announced that its CGuard embolic prevention system reported positive results in the PARADIGM study at the EuroPCR conference, May 22 in Paris. The study was lead by principle...

Micra TPS, world's smallest pacemaker, Heart Rhythm Society, study, MHIF

Results from a clinical trial evaluating the Micra transcatheter pacing system (TPS), the world’s smallest pacemaker, were presented at the Heart Rhythm Society’s 36th annual scientific sessions...

defibrillators, older heart patients, Duke Medicine study, Tracy Wang

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the...

CIEDs, UCSF, UC San Francisco, defibrillator, pacemaker, monitoring, SCD

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) may be underestimating device problems, according to UC San Francisco researchers. They propose systematic...

VHA, dabigatran, patient adherence, JAMA, Mintu Turakhia

Atrial fibrillation patients on the anticoagulant dabigatran were more likely to adhere to the medication with appropriate patient selection and pharmacist-led monitoring, according to a study in...

Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research, The Myth of Restenosis after Carotid Angioplasy and Stenting, at the American...

Xposition S, Stentys, SETUP trial, results, EuroPCR, EuroIntervention

Stentys announced that the findings of the first Xposition clinical experience, as part of the SETUP trial, were presented at the EuroPCR conference in May. The results of this study were also...

Merck, IMPROVE-IT, results, New England Journal of Medicine, NEJM, Vytorin

Merck announced that the New England Journal of Medicine published the results of the IMPROVE-IT trial, an investigational study comparing treatment with Vytorin (ezetimibe and...

Portico, St. Jude Medical, FDA, U.S. evaluation, resume

St. Jude Medical Inc. announced the resumption of the company’s U.S. investigational device exemption (IDE) trial evaluating the Portico transcatheter aortic valve implantation system. The Portico...

Apple, ResearchKit, open software research, medical research apps

In March, Apple announced the launch of ResearchKit, an open source software framework designed for medical and health research. The platform is designed to help doctors and scientists gather data...

Mayo Clinic, CCU, echocardiography, model, mortality, ASE

Researchers announced the results of a study to develop and validate a model, comprised of echocardiographic and clinical data, to predict three-year mortality of patients hospitalized in coronary...

Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures...